Interv Akut Kardiol. 2005;4(3):166-168

Nitrates at the beginning of the 3rd millenium

Tomáš Hodač
I. interní klinika Fakultní nemocnice v Hradci Králové

Although nitrates have a long history, they still continue to be a significant group of commonly used cardiovasclar drugs. Especially in the treatment of heart failure in the terrain of ischaemic heart disease, where they play an irreplaceable role. Most of the knowledge regarding the effects and administration of these drugs is generally known. However, there exist certain interesting and important aspects that are forgotten with time.

Keywords: Key words: nitrates, heart failure, ischaemic heart disease.

Published: January 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hodač T. Nitrates at the beginning of the 3rd millenium. Interv Akut Kardiol. 2005;4(3):166-168.
Download citation

References

  1. Ignarro LJ, Buga, GM, Woods KS, Byrns RE, Chaudhurt G. EDRF produced and released from artery and veins is NO Proc Natl Acad Sci USA 1987; 84: 9265-9269. Go to original source... Go to PubMed...
  2. Murad Ferid Discovery of some of the biological effects of nitric oxide and its role in cell signaling. In: Nobel Lectures, Physiology or Medicine 1996-2000, World Scientific Publishing Co, Singapore, 2003: 210-233.
  3. Ignarro LJ, Murad F Nitric Oxide: biochemistry, molecular biology, and therapeutic implications, Advances in Pharmacology, Volume 34, pp.1-516, Academic Press, 1995. Go to PubMed...
  4. Furchgott R, Zawadski J: The obligatory role of endothelial cells in the ralaxation of arterial smooth muscle to acetylcholine, Nature, 288; 373-376: 1980. Go to original source... Go to PubMed...
  5. Hibbs J, Traintor R, Vanin Z.: Macrophage cytotoxicity. Role for L-arginin deaminase and imino nitrogen activation to nitrate, Science, 235: 473: 1987. Go to original source... Go to PubMed...
  6. Noonan PK, Williams RL, Benet LZ. Dose dependent pharmacokinetics of nitroglycerin after multiple intravenous infusions in healthy volunteers. J Pharmacokinetics Biopharm 13: 143-157; 1985. Go to original source... Go to PubMed...
  7. Hunt SA, Baker DW, Chin MH et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 2001; 38: 2101-13. Go to original source... Go to PubMed...
  8. Gibbons RJ, Abrams J, Chatterjee K et al., ACC/AHA 2002 guideline update for the management of patients with chronic stable angina - summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). J Am Coll Cardiol 2003; 41: 159-68. Go to original source... Go to PubMed...
  9. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: executive summary: a report of the ACC/AHA Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines on the Management of Patients With Acute Myocardial Infarction). J Am Coll Cardiol 2004; 44: 671-719. Go to original source... Go to PubMed...
  10. Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). Circulation 2002 Oct 1; 106(14): 1893-1900. Go to original source... Go to PubMed...
  11. Hildebrandt P, Torp-Pedersen C, Joen T et al., Am Heart J 124; 1139; 1992.




Interventional Cardiology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.